NDC 68135-673-45
Palynziq 20 mg/mL
pegvaliase-pqpz · INJECTION, SOLUTION
Palynziq is a subcutaneous injection used to treat phenylketonuria (PKU), a rare genetic condition where the body cannot properly break down the amino acid phenylalanine. It works by providing an enzyme that helps metabolize phenylalanine and lower its levels in the blood.
Key Facts
- Brand Name
- Palynziq
- Generic Name
- pegvaliase-pqpz
- NDC Code (Package)
68135-673-45- NDC Code (Product)
68135-673- Manufacturer
- BioMarin Pharmaceutical Inc.
- Strength
- 20 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761079
- Drug Class
- Phenylalanine Metabolizing Enzyme [EPC]
- Marketing Start
- 05/24/2018
Recall History
No Recall HistoryView Full Drug Page
Palynziq — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.